Article Details

bluebird bio (NASDAQ:BLUE) Price Target Lowered to $35.00 at Morgan Stanley

Retrieved on: 2021-07-16 13:11:18

Tags for this article:

Click the tags to see associated articles and topics

bluebird bio (NASDAQ:BLUE) Price Target Lowered to $35.00 at Morgan Stanley. View article details on hiswai:

Excerpt

The brokerage presently has an "equal weight" rating on the biotechnology company's stock. Morgan Stanley's price objective would suggest a potential ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up